Kerry Dairy Ireland has rebranded as Kinisla, marking the onset of a significant growth phase for the company.
This extensive Kinisla strategy is designed to promote disciplined and profitable growth in international markets over the next five years. As a venture predominantly owned by farmers, it plans to invest €300 million in advanced manufacturing capabilities, innovative solutions, and efforts to reduce carbon emissions.
The company embarks on this new phase with impressive operational dynamics. By 2025, turnover reached €1.4 billion, and EBITDA increased to €86.8 million. To capitalize on this success, the board has sanctioned a focused investment plan totaling €300 million.
In addition, Kinisla intends to create 100 new positions in central operations within the coming one to two years. This funding will be strategically directed toward areas with the highest potential for long-term margins, particularly in nutritional ingredients and dairy consumer products.
Pat Murphy, the CEO of Kinisla, commented on the strategic vision driving the financial results: “2025 was a landmark year for Kinisla and one that underlines the strength of the farmer-owned business we are building. We delivered a strong performance, with turnover of €1.4 billion and significant momentum across key parts of the portfolio, particularly Nutritional Ingredients and Dairy Consumer Foods.”
Kinisla’s initiative addresses fundamental challenges faced by product developers. The swift global embrace of GLP-1 medications for weight management is altering consumer food tastes. Individuals utilizing these treatments now prefer smaller, highly nutrient-rich food options.
The company is strategically aligning its ingredient offerings to meet this growing consumer trend. Kinisla supplies clean-label protein fractions that seamlessly integrate into wellness bars and ready-to-drink beverages.
Moreover, this investment supports Kinisla’s exclusive Ultranor milk protein line, known for its remarkable heat stability during rigorous ultra-high temperature processing. Beverage makers can achieve high-protein formulations without the undesirable chalky texture or unpleasant mouthfeel.
Additionally, Kinisla’s Hyprol hydrolyzed proteins are tailored for specialized clinical nutrition brands. The research and development team can modify these hydrolysates to adhere to strict mineral content requirements for at-risk patient demographics. Meanwhile, Dairyborn functional cheeses ensure optimal melt characteristics for pizza offerings in the international foodservice market.
James Tangney, chairman of Kinisla, highlighted the strategic vision that underpins long-term sustainability: “The investment we are committing to over the next five years is about building a business that delivers on milk price, sustainability, and long-term growth. Kinisla is the identity under which we will successfully build that future for our farmers and the communities connected to them.”